Ana M. Arance
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 143 publications
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 12, 2026
Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 13, 2026
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.
Journal: Journal for immunotherapy of cancer
Published: March 31, 2026
Therapeutic Drug Monitoring and Model-Informed Precision Dosing of Oral TKIs and PARP Inhibitors: A Practical Framework for Clinical Implementation.
Journal: Clinical pharmacokinetics
Published: February 25, 2026
IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 31, 2025
Nivolumab for Resected Stage III or IV Melanoma at 9 Years.
Journal: The New England journal of medicine
Published: October 22, 2025
Exploratory Analysis of Biomarkers and Treatment Outcomes from the COLUMBUS Study in BRAF V600E/K-Mutant Advanced or Metastatic Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 23, 2025
Erratum: BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 24, 2025
BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 27, 2025
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial.
Journal: ESMO open
Published: June 16, 2025
Assessing brain metastasis response to immunotherapy: a pictorial review of atypical responses and intracranial adverse events.
Journal: Insights into imaging
Published: June 08, 2025
Last Updated: 09/26/2026